Article

Monoclonal antibody and antiviral therapy for treatment of mild-to-moderate COVID-19 in pediatric patients

2022-03-18

Abstract excerpt

The recent surge of SARS-CoV-2 Omicron variant (B.1.1.529) coincided with new treatment options for mild-to-moderate Covid-19 in high-risk adolescents and adults. In this report we describe patient characteristics, treatment-related process measures and outcomes associated with early Covid-19 therapy in high-risk pediatric patients.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 256c05ad-4a86-5013-a027-7898731016f9
DOI: 10.1101/2022.03.16.22272511

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Monoclonal antibody and antiviral therapy for treatment of mild-to-moderate COVID-19 in pediatric patientsDOI 10.1101/2022.03.16.22272511Read

Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions.Semantic proximity Read

Epidemiological, clinical and biomarker profile of pediatric patients infected with COVID-19Semantic proximity Read

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19Semantic proximity Read

Consensus on COVID-19 vaccination in pediatric oncohematological patients, on behalf of infectious working group of Italian Association of Pediatric Hematology OncologySemantic proximity Read

COVID-19 in pediatric cancer: where are the brain tumors?Semantic proximity Read

Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 TrialSemantic proximity Read

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: a phase 3, randomized, placebo-controlled trial (PREVENT-19)Semantic proximity Read

Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney DiseasesSemantic proximity Read

Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS- CoV-2 infection – a single-centre, retrospective, cohort studySemantic proximity Read

Omicron Variant of SARS-CoV-2, an epidemiologic assessment of pediatric oncology patients in the BronxSemantic proximity Read

Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responsesSemantic proximity Read

Emergence of SARS-CoV-2 variants of concern in the pediatric population of the United StatesSemantic proximity Read